Management of the N3 neck

Karen Pitman, Patrick J. Bradley

Research output: Contribution to journalReview article

Abstract

Management options for patients with advanced neck node metastasis from head and neck cancer are controversial. Typically, N3 disease suggests a poor outcome because of difficulty with regional control and the high likelihood of distant metastases. Patients who are treated for cure are treated with aggressive multimodality treatment. Therefore, a critical assessment of the potential for cure or measurable palliation, patient comorbidity, and the risk of complications when considering treatment for patients with N3 disease figures prominently in treatment planning. The pretreatment evaluation and contemporary management of patients with N3 disease are discussed in this review.

Original languageEnglish (US)
Pages (from-to)129-133
Number of pages5
JournalCurrent Opinion in Otolaryngology and Head and Neck Surgery
Volume11
Issue number2
DOIs
StatePublished - Apr 2003
Externally publishedYes

Fingerprint

Neck
Neoplasm Metastasis
Head and Neck Neoplasms
Comorbidity
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Management of the N3 neck. / Pitman, Karen; Bradley, Patrick J.

In: Current Opinion in Otolaryngology and Head and Neck Surgery, Vol. 11, No. 2, 04.2003, p. 129-133.

Research output: Contribution to journalReview article

Pitman, Karen ; Bradley, Patrick J. / Management of the N3 neck. In: Current Opinion in Otolaryngology and Head and Neck Surgery. 2003 ; Vol. 11, No. 2. pp. 129-133.
@article{b3299723b05642208aa5df160b59ae55,
title = "Management of the N3 neck",
abstract = "Management options for patients with advanced neck node metastasis from head and neck cancer are controversial. Typically, N3 disease suggests a poor outcome because of difficulty with regional control and the high likelihood of distant metastases. Patients who are treated for cure are treated with aggressive multimodality treatment. Therefore, a critical assessment of the potential for cure or measurable palliation, patient comorbidity, and the risk of complications when considering treatment for patients with N3 disease figures prominently in treatment planning. The pretreatment evaluation and contemporary management of patients with N3 disease are discussed in this review.",
author = "Karen Pitman and Bradley, {Patrick J.}",
year = "2003",
month = "4",
doi = "10.1097/00020840-200304000-00012",
language = "English (US)",
volume = "11",
pages = "129--133",
journal = "Current Opinion in Otolaryngology and Head and Neck Surgery",
issn = "1068-9508",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Management of the N3 neck

AU - Pitman, Karen

AU - Bradley, Patrick J.

PY - 2003/4

Y1 - 2003/4

N2 - Management options for patients with advanced neck node metastasis from head and neck cancer are controversial. Typically, N3 disease suggests a poor outcome because of difficulty with regional control and the high likelihood of distant metastases. Patients who are treated for cure are treated with aggressive multimodality treatment. Therefore, a critical assessment of the potential for cure or measurable palliation, patient comorbidity, and the risk of complications when considering treatment for patients with N3 disease figures prominently in treatment planning. The pretreatment evaluation and contemporary management of patients with N3 disease are discussed in this review.

AB - Management options for patients with advanced neck node metastasis from head and neck cancer are controversial. Typically, N3 disease suggests a poor outcome because of difficulty with regional control and the high likelihood of distant metastases. Patients who are treated for cure are treated with aggressive multimodality treatment. Therefore, a critical assessment of the potential for cure or measurable palliation, patient comorbidity, and the risk of complications when considering treatment for patients with N3 disease figures prominently in treatment planning. The pretreatment evaluation and contemporary management of patients with N3 disease are discussed in this review.

UR - http://www.scopus.com/inward/record.url?scp=0037378831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037378831&partnerID=8YFLogxK

U2 - 10.1097/00020840-200304000-00012

DO - 10.1097/00020840-200304000-00012

M3 - Review article

VL - 11

SP - 129

EP - 133

JO - Current Opinion in Otolaryngology and Head and Neck Surgery

JF - Current Opinion in Otolaryngology and Head and Neck Surgery

SN - 1068-9508

IS - 2

ER -